Environmental exposures can raise the risk of developing autoimmune disorders by altering immune regulation, provoking chronic inflammation, or exposing the immune system to molecules that resemble self-antigens. Mechanisms include molecular mimicry, chronic immune activation, and epigenetic modifications that change gene expression in immune cells. Yehuda Shoenfeld, Tel Aviv University, has written extensively about how adjuvants and persistent environmental stimuli can precipitate autoimmunity in susceptible hosts, highlighting the interplay between external agents and genetic risk.
Respiratory and occupational exposures
Tobacco smoke is one of the best-documented environmental risk factors. Research by Lars Klareskog, Karolinska Institutet, demonstrated a strong association between cigarette smoking and anti-citrullinated protein antibody positive rheumatoid arthritis, particularly in people carrying specific HLA-DRB1 risk alleles; smoking promotes lung inflammation and post-translational protein modifications that can break immune tolerance. Silica dust and other mineral exposures, common in mining, construction, and stonework, have been linked to increased incidence of systemic autoimmune diseases including systemic lupus erythematosus and rheumatoid arthritis; public health guidance from the Centers for Disease Control and Prevention describes occupational silica exposure as a preventable risk. Organic solvents and certain industrial chemicals have been associated with autoimmune thyroid disease and systemic sclerosis in occupational cohorts, a pattern summarized in reviews by the National Institute of Environmental Health Sciences.
Infections, chemicals, and lifestyle factors
Persistent or past infections can trigger autoimmunity through molecular mimicry and sustained immune activation. Epstein-Barr virus has been implicated as a major environmental contributor to multiple sclerosis in large epidemiologic studies, and scholars such as Alberto Ascherio, Harvard T.H. Chan School of Public Health, have evaluated how infections interact with other exposures like vitamin D insufficiency and obesity to modulate MS risk. Pesticides and herbicides used in agriculture are associated in some studies with increased autoimmune and inflammatory disorders; the World Health Organization emphasizes careful regulation and monitoring in regions with heavy agricultural chemical use. Heavy metals such as mercury and certain adjuvants have been proposed to alter immune responses, with work by Shoenfeld and others exploring how low-level chronic exposures may be important in predisposed individuals.
Consequences of these environmental risks extend beyond individual disease to public health and social systems. Autoimmune diseases disproportionately affect women and often emerge during working ages, creating long-term disability and healthcare costs; communities with concentrated occupational hazards or limited regulatory oversight—rural agricultural regions, informal mining areas, and certain industrial zones—may experience higher burdens. Cultural practices that affect exposure patterns, such as indoor cooking with biomass, tobacco use, or limited access to protective equipment, modify local risk.
Addressing environmental drivers requires combining individual clinical vigilance with policy and prevention: reducing occupational exposures, regulating hazardous chemicals, smoking cessation programs, vaccination and infection control where relevant, and improving nutrition and vitamin D status in communities at risk. Mitigating exposures can lower population-level autoimmune risk even when genetic susceptibility remains unchanged.